Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
3.770
-0.030 (-0.79%)
At close: Dec 5, 2025, 4:00 PM EST
3.610
-0.160 (-4.24%)
After-hours: Dec 5, 2025, 5:01 PM EST
Cellectar Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 16 | 12 | 34 | 16 | 41 | 94 | |
| Market Cap Growth | -78.10% | -63.75% | 112.09% | -60.44% | -57.05% | 346.76% | |
| Enterprise Value | 4 | -6 | 35 | -0 | 2 | 77 | |
| Last Close Price | 3.77 | 8.97 | 83.10 | 51.30 | 199.20 | 624.00 | |
| PB Ratio | 1.61 | 0.79 | -2.47 | 1.68 | 1.23 | 1.72 | |
| P/TBV Ratio | 2.14 | 0.90 | - | 1.97 | 1.28 | 2.72 | |
| Debt / Equity Ratio | 0.05 | 0.03 | -0.04 | 0.06 | 0.01 | 0.01 | |
| Quick Ratio | 2.56 | 2.48 | 0.38 | 1.73 | 8.95 | 16.04 | |
| Current Ratio | 2.77 | 2.58 | 0.41 | 1.79 | 9.16 | 16.26 | |
| Return on Equity (ROE) | -145.42% | -4693.38% | - | -149.33% | -54.92% | -47.28% | |
| Return on Assets (ROA) | -72.31% | -172.36% | -144.66% | -61.26% | -31.47% | -26.95% | |
| Return on Capital (ROIC) | -139.71% | -2196.39% | - | -82.83% | -34.06% | -29.49% | |
| Return on Capital Employed (ROCE) | -309.10% | -321.90% | 293.30% | -285.60% | -72.70% | -27.80% | |
| Earnings Yield | -117.93% | -361.29% | -125.65% | -198.10% | -59.46% | -15.98% | |
| FCF Yield | -186.10% | -386.45% | -97.66% | -158.57% | -55.98% | -14.82% | |
| Buyback Yield / Dilution | -93.70% | -203.92% | -73.22% | -27.09% | -180.20% | -158.14% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.